A recent report has suggested that anti-Ro/SSA correlated with longer disease duration and higher intensity of lymphocytic infiltrates invading the LSG [44], while the SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of SS [45]. The gene discussed is CALR; the disease is synovial sarcoma.